C

Cellestia Biotech

19 employees

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Biotech
Oncology
Targeted Therapy
Cancer Therapy
Health Care
Therapeutics
Inflammatory Disorders
Transcription Factors
Small Molecules
Biopharma
Autoimmune Disorders
Precision Medicine

Date founded

2014

Funding rounds raised

Total raised

$20M

from 8 investors over 8 rounds

C

Cellestia Biotech raised undisclosed on June 27, 2023

Investors: swissnex San Francisco

C

Cellestia Biotech raised undisclosed on March 9, 2022

Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung

C

Cellestia Biotech raised undisclosed on August 17, 2021

Investors: SNGLR Group

C

Cellestia Biotech raised $20M on December 17, 2019

Investors: Partners Investment

C

Cellestia Biotech raised $82K on January 1, 2019

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

C

Cellestia Biotech raised undisclosed on May 7, 2018

Investors: GoBeyond

C

Cellestia Biotech raised $8M on January 26, 2017

Investors: GoBeyond

C

Cellestia Biotech raised undisclosed on March 28, 2016

Investors: GoBeyond

FAQ